0001140361-13-046217.txt : 20131213 0001140361-13-046217.hdr.sgml : 20131213 20131213193722 ACCESSION NUMBER: 0001140361-13-046217 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131211 FILED AS OF DATE: 20131213 DATE AS OF CHANGE: 20131213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN INC. CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: MYLAN LABORATORIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RIZZO DANIEL C JR CENTRAL INDEX KEY: 0001184392 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 131277476 MAIL ADDRESS: STREET 1: GARDNER DENVER, INC. STREET 2: 1800 GARDNER EXPRESSWAY CITY: QUINCY STATE: IL ZIP: 62305 4 1 doc1.xml FORM 4 X0306 4 2013-12-11 0 0000069499 MYLAN INC. MYL 0001184392 RIZZO DANIEL C JR 1500 CORPORATE DRIVE CANONSBURG PA 15317 0 1 0 0 SVP, Corp Controller & CAO Common Stock 2013-12-11 4 M 0 2895 20.87 A 64912 D Common Stock 2013-12-11 4 S 0 2895 42.3709 D 62017 D Common Stock 2013-12-11 4 M 0 2562 21.13 A 64579 D Common Stock 2013-12-11 4 S 0 2562 42.3224 D 62017 D Common Stock 2013-12-11 4 M 0 2263 22.66 A 64280 D Common Stock 2013-12-11 4 S 0 2263 42.2665 D 62017 D Common Stock 2013-12-11 4 M 0 2305 23.44 A 64322 D Common Stock 2013-12-11 4 S 0 2305 42.2640 D 62017 D Common Stock 2013-12-11 4 M 0 6954 21.13 A 68971 D Common Stock 2013-12-12 4 M 0 42105 20.87 A 111076 D Common Stock 2013-12-12 4 S 0 42105 42.00 D 68971 D Common Stock 2013-12-12 4 M 0 4872 21.13 A 73843 D Common Stock 2013-12-12 4 S 0 4872 42.00 D 68971 D Common Stock 2013-12-12 4 M 0 9400 22.66 A 78371 D Common Stock 2013-12-12 4 S 0 9400 42.00 D 68971 D Common Stock 2013-12-12 4 M 0 4281 23.44 A 73252 D Common Stock 2013-12-12 4 S 0 4281 42.00 D 68971 D Common Stock 382 I By 401(k) Plan Stock Option Right to Buy 20.87 2013-12-11 4 M 0 2895 0 D 2016-05-30 Common Stock 2895 42105 D Stock Option Right to Buy 21.13 2013-12-11 4 M 0 16758 0 D 2020-03-03 Common Stock 16758 4872 D Stock Option Right to Buy 22.66 2013-12-11 4 M 0 2263 0 D 2021-03-02 Common Stock 2263 15231 D Stock Option Right to Buy 23.44 2013-12-11 4 M 0 2305 0 D 2022-02-22 Common Stock 2305 17451 D Stock Option Right to Buy 20.87 2013-12-12 4 M 0 42105 0 D 2016-05-30 Common Stock 42105 0 D Stock Option Right to Buy 21.13 2013-12-12 4 M 0 4872 0 D 2020-03-03 Common Stock 4872 0 D Stock Option Right to Buy 22.66 2013-12-12 4 M 0 9400 0 D 2021-03-02 Common Stock 9400 5831 D Stock Option Right to Buy 23.44 2013-12-12 4 M 0 4281 0 D 2022-02-22 Common Stock 4281 13170 D Represents the weighted average price of the reporting person's disposition of 2,895 shares in transactions ranging from $42.00 to $42.61. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 3, 4, and 5 to this Form 4. Represents the weighted average price of the reporting person's disposition of 2,562 shares in transactions ranging from $42.00 to $42.61. Represents the weighted average price of the reporting person's disposition of 2,263 shares in transactions ranging from $42.00 to $42.48. Represents the weighted average price of the reporting person's disposition of 2,305 shares in transactions ranging from $42.00 to $42.45. The officer has entered into an attestation stock swap whereby the option exercise costs have been covered by long shares owned which resulted in a net amount of 6,954 shares. This option exercise and the related sale of the underlying common stock were executed pursuant to an amended 10b5-1 trading plan dated December 10, 2013. The options vested in three equal installments on May 30, 2007, 2008, and 2009. The options vested in three equal installments on March 3, 2011, 2012, and 2013. Two-thirds of these options vested in equal installments on March 2, 2012 and 2013. The remainder of these options will vest on March 2, 2014. One-third of these options vested on February 22, 2013. The remainder of these options will vest in equal installments on February 22, 2014, and 2015. /s/ Daniel C. Rizzo, Jr. 2013-12-13